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Introduction: Scrapie and bovine spongiform encephalopathy (BSE) are transmissible spongiform encephalopathies
(TSEs) which naturally affect small and large ruminants respectively. However, small ruminants, which are
susceptible to BSE under experimental conditions, have been exposed to the same or similar contaminated food
additives as cattle. To date two natural cases of BSE in small ruminants have been reported. As a result surveillance
projects, combined with appropriate control measures, have been established throughout the European Union (EU)
to minimize the overall incidence of small ruminant TSEs. Although BSE can be differentiated from classical scrapie
(subsequently referred to as scrapie) if appropriate discriminatory tests are applied, the value of these tests in
BSE/scrapie co-infection scenarios has not been evaluated fully. Mouse bioassay is regarded as the gold standard
regarding differentiation of distinct TSE strains and has been used as to resolve TSE cases were laboratory tests
produced equivocal results. However, the ability of this method to discriminate TSE strains when they co-exist has
not been examined systematically. To address this issue we prepared in vitro mixtures of ovine BSE and scrapie and
used them to challenge RIII, C57BL/6 and VM mice.
Results: Disease phenotype analysis in all three mouse lines indicated that most phenotypic parameters (attack
rates, incubation periods, lesion profiles and Western blots) were compatible with scrapie phenotypes as were
immunohistochemistry (IHC) data from RIII and C57BL/6 mice. However, in VM mice that were challenged with
BSE/scrapie mixtures a single BSE-associated IHC feature was identified, indicating the existence of BSE in animals
where the scrapie phenotype was dominant.
Conclusions: We conclude that wild type mouse bioassay is of limited value in detecting BSE in the presence of
scrapie particularly if the latter is in relative excess.
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Classical scrapie (subsequently referred to as scrapie)
and Bovine Spongiform Encephalopathy (BSE) are trans-
missible spongiform encephalopathies (TSEs), a group of
fatal neurodegenerative disorders of animals and man
which are characterised by the deposition of a misfolded
isoform (PrPSc or prion) of a cellular protein (PrPC),
spongiosis and gliosis. Even though scrapie has been* Correspondence: john.spiropoulos@apha.gsi.gov.uk
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unless otherwise stated.endemic in sheep and goats for centuries it is believed
not to have represented a risk for human health [1,2].
On the contrary, BSE is a relatively new prion disease
[3], and has been linked with variant Creutzfeldt-Jakob
disease (vCJD) a form of CJD which usually affects
young subjects [4-6].
The origin of BSE is still unclear. Two main theories
suggest either a sporadic cattle disease or a cattle-
adapted form of scrapie that crossed the species barrier
[7,8]. The recycling of ruminant tissue into meat and
bone meal, which was commonly fed as an ingredient of
concentrated feed supplements, in combination withhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in the UK in the 1980s, exposed not only cattle but also
small ruminants to infectious prions [8,9]. Furthermore,
experimental challenge of small ruminants with BSE
proved that they are susceptible, resulting in a disease
with clinical signs that are indistinguishable from those
caused by scrapie [10,11]. Such studies have provided
invaluable materials for the development of immuno-
chemical and immunohistochemical discriminatory tests
that have the ability to differentiate between BSE and
scrapie [12-17].
Application of these discriminatory tests in national
surveillance schemes is now a statutory requirement,
and has revealed a caprine BSE case in France [18].
Retrospectively, another caprine TSE case was identified
and confirmed as BSE in the UK [19,20]. Part of this
statutory process is the confirmation of the suspicion of
BSE by mouse bioassay.
Although the discriminatory tests have been validated
rigorously on the basis that a small ruminant may be
affected by either BSE or scrapie, their performance on
samples where BSE and scrapie prions concur has not
been tested despite evidence that co-infection by mul-
tiple TSE strains in a single animal is plausible [21-23].
Therefore the possibility that sheep in commercial hold-
ings might have been affected by BSE from feed, which
subsequently remains undetected due to the simultan-
eous presence of scrapie, cannot be excluded unequivo-
cally. In contrast to the pathogenesis of BSE in cattle
where the PrPSc distribution is predominantly detectable
in the central nervous system, except for a short period
after oral challenge where it can be identified in the
Peyer’s patches and in the myenteric plexus of the distal
ileum [24,25], the peripheral pathogenesis of BSE in
sheep is similar to that of scrapie with extensive accu-
mulation of the infectious agent in peripheral tissues
[26,27]. This widespread distribution of the infectious
agent is considered to be the main factor responsible for
sheep-to-sheep transmission of scrapie [28] and similarly
BSE infectivity in a flock could reasonably be sustained
even after the original source of infection is eliminated.
Recent evidence suggesting that natural transmission of
BSE in sheep can occur [29] seems to confirm this
hypothesis. This possibility warrants careful consider-
ation, since the widespread peripheral distribution of
BSE prions in sheep suggests that measures that were
responsible for the successful eradication of BSE from
the cattle population would appear inadequate to elimin-
ate BSE in sheep. Indeed this makes it virtually impos-
sible to ensure absence of BSE infectivity to consumers
after consumption of sheep meat or its products [27].
It is evident that there is a clear need to detect BSE in
small ruminants not just when it is the only infectious
prion present but also when it may co-exist with scrapie,possibly in the same animal. Under such conditions
discrimination of BSE from scrapie may not be straight-
forward since, according to the only experimental co-
infection study where mice were challenged with mixtures
of mouse adapted BSE and scrapie, only the scrapie
phenotype was recognised based on differing electrophor-
etic properties of PrPSc [30]. This suggests that scrapie
masked the BSE signal in the original inoculum and that
following transmission to mice scrapie either propagated
at the expense of BSE or the scrapie phenotype masked
any signal that might had been generated by simultaneous
propagation of the BSE agent.
Despite the potentially high exposure of small rumi-
nants to BSE-contaminated feeds only a small propor-
tion of BSE cases were identified throughout Europe,
both of them in goats. No BSE has been currently de-
tected in sheep worldwide. This has led to the belief that
if BSE had entered in the sheep population the infectiv-
ity levels would be low, and in such cases it could escape
diagnosis if it resided in sheep which were also infected
with a high scrapie titre. In this study we investigated
the ability of wild type mouse bioassay to identify BSE
when it is present in an excess of scrapie during primary
isolation using histopathology, immunohistochemistry
(IHC) and Western blot.
Results
Attack rate (AR), hit rate (HR) and incubation period (IP)
analysis
The AR and HR of all isolates are presented in Table 1.
AR is defined as the ratio of TSE positive animals over
the total number of challenged animals. HR is defined as
the ratio of TSE positive animals over the number of an-
imals encountered after the first TSE positive animal. In
our view, AR is considered to be a better indicator of
transmissibility than HR when species barriers have to
be overcome, particularly when they have an adverse ef-
fect on transmissibility. Therefore, for the remainder of
the paper only AR will be considered although HR data
are also presented for comparative purposes.
The IP data are expressed as days post inoculation
(dpi) and are based on TSE positive mice that exhibited
clinical signs of neurological disease (Table 1 and Figure 1).
Generally there is too big an overlap between all inocula
to allow any discrimination even between the controls,
100% scrapie and 100% BSE. The only notable observation
was the prolonged IP of the 100% BSE source in C57BL/6
mice compared to all other isolates. The variance of IP
in this group of mice was also increased when com-
pared with the other C57BL/6 groups. Another, subtle
difference was that in VM mice the mean IP of the
100% scrapie source was shorter than 600 dpi whilst
the 100% BSE source and all the mixtures produced IP
longer than 600 dpi. However this difference was not
Table 1 Attack rate (AR), hit rate (HR) and incubation period (IP) of scrapie/BSE mixtures inoculated in three wild type
mouse lines
Mouse line Bioassay parameters Inoculum
100% scrapie 1% BSE 2% BSE 10% BSE 50% BSE 100% BSE
RIII AR 0.95 0.95 0.80 0.95 0.80 0.80
HR 1.00 1.00 1.00 1.00 1.00 0.94
IP 459 ± 17 457 ± 17 461 ± 17 458 ± 15 473 ± 17 424 ± 52
C57 AR 0.90 0.95 0.85 0.90 0.95 0.75
HR 1.00 1.00 1.00 1.00 1.00 0.88
IP 464 ± 34 481 ± 22 448 ± 48 485 ± 24 491 ± 36 595 ± 77
VM AR 0.90 1.00 1.00 0.95 1.00 1.00
HR 1.00 1.00 1.00 1.00 1.00 1.00
IP 579 ± 86 635 ± 85 635 ± 62 666 ± 61 629 ± 100 638 ± 64
AR (Attack Rate) is the ratio of confirmed TSE positive mice over the number of inoculated mice (n = 20).
HR (Hit Rate) is the ratio of TSE positive mice over the number of animals encountered after the first positive clinical animal.
IP (Incubation Period) was recorded as days post inoculation and values indicate mean ± standard deviation. Only clinically and TSE confirmed positive mice were
included in the IP assessment.
Figure 1 Incubation period data of RIII, C57BL/6 and VM mice. Animals were inoculated with various BSE/scrapie mixtures and the BSE and
scrapie sources that were used to produce the mixtures. In the mixtures only the percentage of BSE is indicated; the remaining reflects scrapie
percentage. Circles indicate individual mice, vertical lines indicate the mean of the group. RIII, red; C57BL/6, black; VM, green.
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Figure 2 Lesion profiles from RIII, C57BL/6 and VM mice. RIII (a),
C57BL/6 (b) and VM (c) mice were inoculated with various BSE/scrapie
mixtures and the BSE and scrapie sources that were used to produce
the mixtures. BSE/scrapie mixtures are indicated by blue (1%BSE), red
(2%BSE), amber (10%BSE) and brown (50%) lines; scrapie control, green
line; BSE control, black line.
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test).
Both 100% scrapie and 100% BSE generated high AR.
Compared to other inocula of the same TSEs prepared
from terminally ill animals and bioassayed in our la-
boratory the IP values observed in this study were
similar to the lower end of the IP data range indicating
that that each source represented an origin of high
infectivity [16,31].
Lesion profile (LP) analysis
Due to the high infectivity of all inocula there were at
least five clinically and pathologically positive mice in
each mouse group. Therefore it was feasible to construct
LP from each mouse group (Figure 2).
In the RIII mice the LP from mixtures appear to be
more akin to the LP of the 100% scrapie source (Figure 2a).
However, both the 100% BSE and 100% scrapie produced
LP which showed similar contours, the main differences
between the two being quantitative. This property of the
RIII mice has been reported elsewhere and the scrapie as-
sociated profile has been designated 1-4-7-scrapie to de-
note its similarity to BSE induced LP [16] which also
produces consistent LP with peaks in the same brain areas
[32]. The 1-4-7-scrapie LP has only been derived from
ARQ/ARQ scrapie sources [16,31]. In the current study
the 100% scrapie source consisted mainly of VRQ/VRQ
(45.16%) and ARQ/VRQ (9.68%) sources whist the ARQ/
ARQ content was 40.32%.
The LP differences between the 100% BSE and 100%
scrapie sources were more profound in C57BL/6 and
VM mice, where they resulted in different LPs. The LPs
that were generated from the various mixtures in these
two mouse lines aligned more closely to the LP from the
100% scrapie control than the 100% BSE isolate.
In addition application of cluster analysis based on the
lesion scores, showed that in all three mouse lines the
BSE/scrapie mixtures grouped together with the 100%
scrapie control which was distinct from the 100% BSE
control (Additional file 1: Figure S1).
Estimation of PrPSc levels in the source BSE and scrapie
inocula
The PrPSc levels in the 100% BSE and 100% scrapie ho-
mogenates were estimated using IDEXX Herdchek BSE –
scrapie EIA kit, an ELISA-based commercially available
TSE diagnostic method. Based on this approach compari-
son between BSE and scrapie sources indicated that the
PrPSc levels in the 100% Scrapie homogenate were 2.6 logs
higher compared to the 100% BSE inoculum (Figure 3).
Western blot analysis
Application of Western blot to the inocula that were
used to challenge the mice showed that all the mixturesessentially behaved as scrapie, showing a higher mo-
lecular weight unglycosylated band compared to BSE
(Figure 4a) and a strong binding affinity for antibody
12B2 (Figure 4b).
Application of Western blot to the brains of C57BL/6
and RIII mice showed that even animals that were
Figure 3 Comparison of PrPSc levels in BSE and scrapie inocula
as determined by IDEXX EIA. Both inocula, 100% BSE (■) and
100% scrapie (●), were analysed by IDEXX Herdchek BSE/scrapie EIA
as described in Materials and methods. Colour development,
measured in absorbance units (AU), is proportional to the amount of
PrPSc in the sample when the growth phase of the curve is linear.
Required inocula dilutions to achieve an AU value of 0.6, where the
growth phase of the 100% BSE curve was most linear, were 1/912
for 100% scrapie and 1/2.5 for 100% BSE, indicating the quantity of
PrPSc in the scrapie inocula was 357 times greater than in the BSE
inocula. OD values of ovine BSE and ovine scrapie positive controls
were 2.659 and 2.664 AU respectively. OD values of two control
negative sheep samples were 0.064 and 0.057 AU.
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BSE) were indistinguishable from those that were chal-
lenged with the scrapie control, showing a high mo-
lecular weight unglycosylated band compared to the
BSE control (Figure 5). A fourth band running approxi-
mately 2 kDa below the unglycosylated band was
observed in all murine scrapie samples. This, otherwise
faint, band became prominent when the gels were
visualised using antibody 12B2. This band is thought to
represent C-terminal cleavage products of PrPSc. Mice
inoculated with BSE/scrapie mixtures where the rela-
tive proportion of BSE was less than 50% also showed a
Western blot phenotype that was indistinguishable
from that induced by scrapie (data not shown). No
attempt was made to apply Western blot to VM mice
as in this mouse line BSE cannot be distinguished from
scrapie using this technique [33].Immunohistochemical (IHC) analysis
Slides were divided into three groups, according to the
three mouse lines used: C57BL/6, RIII and VM.
All slides were interpreted by a single assessor. During
the first phase, the 100% BSE and 100% scrapie samples
were evaluated unblinded, for the reader to identify the
hallmarks of the PrPSc patterns associated with each
agent [34-36]. The remaining slides, which derived from
mice inoculated with 1%, 2%, 20% and 50% BSE, were all
mixed randomly and potential IHC markers assessed
blind by the reader (Phase 1).
At the end of Phase 1 it was concluded that it was not
possible to recognise any BSE associated markers in ei-
ther C57BL/6 or RIII mice challenged with BSE/scrapie
mixtures as all animals showed a single phenotype that
was indistinguishable from the phenotype induced by
the 100% scrapie control. In VM mice challenged with
BSE/scrapie mixtures, however, a single PrPSc type which
was initially observed in VM mice challenged with BSE
but not with scrapie, designated ‘BSE-associated punc-
tate pattern’, was identified (Figure 6). This PrPSc type
appeared to be present in a number of BSE/scrapie chal-
lenged mice that otherwise had a scrapie compatible
IHC phenotype. Subsequently, this BSE specific PrPSc
type was assessed semi-quantitatively on a scale 0 to 4
(0 = none, 1 = inconclusive, 2 = mild, 3 = moderate and
4 = abundant) in different neuroanatomical areas, lo-
cated at four coronal levels (medulla, midbrain, thal-
amic and frontal) in all BSE/scrapie challenged mice.
This assessment, which was performed blind, revealed
that this pattern was more abundant in mice that were
challenged with mixtures with a higher BSE concentra-
tion, both in terms of quantity in the different neuroana-
tomical areas (Figure 7) and its distribution throughout
the brain (Figure 8).
Based on the previous finding that the BSE-associated
punctate PrPSc type can be observed in BSE/scrapie mix-
tures, all samples derived from VM mice challenged not
only with BSE/scrapie mixtures but also with 100% BSE
or 100% scrapie were mixed randomly and assessed
blind by the same operator (Phase 2). The presence of
BSE-associated punctate deposits in specific neuroana-
tomical areas allocated in the four coronal levels was
recorded. At each coronal level the number of neuro-
anatomical areas affected by BSE-associated punctate
deposits was used to predict the presence and percentage
of BSE in the original inoculum. The test predictions were
compared to the actual values and the associations be-
tween test and true status were not random (p < 0.0001
by Fisher’s exact test). The sensitivity, specificity and ac-
curacy of the approach were 78% (62–89), 91% (75–98)
and 84% (73–91); values in brackets denote 95% confi-
dence intervals. The predictions were more accurate in
the high BSE content inocula (50% and 10%) whilst the
Figure 4 Western blot analysis of inocula homogenates that were used to challenge the mice. Western blots were performed as described
in Materials and methods using antibodies Sha31 (a and b) and 12B2 (c and d). Images a and c compare the western blot profiles obtained for
the two different methods used to extract samples; solid tissues (T) and inocula (I). Images b and d show western blot profiles observed for the
different prepared inolcula: 100% BSE (B), 50% BSE (50), 10% BSE (10), 2% BSE (2), 1% BSE (1) and 100% scrapie (S). For BSE/scrapie mixtures only
the percentage BSE is indicated; the remainder indicates the percentage of scrapie. All inocula represent 10% (w/v) brain tissue in normal saline.
An inoculum prepared from a TSE negative sheep was also analysed by Western blot (N). Molecular mass markers (M) are indicated in kDa. For
(a) and (c) each sample was diluted to achieve optimum representation of banding profile; dilution of each source between (a) and (c) was kept
constant. For (b) and (d) each lane was loaded with 15 μl of neat extracted sample, equivalent to 30 mg of brain tissue.
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cult to predict accurately.
Discussion
Despite the significant progress and development of tests
that can discriminate BSE from scrapie in a single infec-
tion scenario, limited studies have been conducted that
address the performance of the discriminatory tests inFigure 5 Western blot analysis of mice inoculated with BSE/scrapie m
methods using antibodies Sha31 (a) and 12B2 (b). Western blots show thre
BSE (50% BSE) and 100% scrapie (S). Brain tissue from an unchallenged mo
kDa. All samples were extracted from fresh frozen tissue. Each lane was loa
brain tissue.cases where BSE and scrapie exist in the same animal.
Ideally, the best possible experimental materials should
derive from sheep co-infected experimentally with nat-
ural scrapie and BSE sources via natural routes of inocu-
lation i.e. under conditions that would reflect most
closely a naturally occurring co-infection. To the best of
our knowledge, however, materials from such experi-
ments are not widely available. Therefore we used theixtures. Western blots were performed as described in Materials and
e mouse lines (C57BL/6, RIII & VM) challenged with 100% BSE (B), 50%
use (N) was also analysed. Molecular mass markers (M) are indicated in
ded with 15 μl of neat extracted sample, equivalent to 30 mg of
Figure 6 Detection of PrPSc types using immunohistochemistry in mouse brains. Mice challenged with BSE show BSE-characteristic punctuate
PrPSc deposits (a, b) which are the only evident BSE feature in mice challenged with BSE/scrapie mixtures (c, d) in a pattern that is otherwise
indistinguishable from scrapie (e, f). The content of BSE in the BSE/scrapie mixture used to inoculate the mice shown in c and d was 50%; a, c, e
superior coliculus; b, d, f thalamus. Scale bar represents 50 μm. PrPSc was detected with a polyclonal rabbit antibody Rb486 diluted 1/2000.
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pie mixtures in vitro and used them as a substitute to
co-infected tissue. Both BSE and scrapie inocula were
prepared from animals at the terminal stage of the dis-
ease to ensure maximum infectivity. However, measure-
ment of PrPSc levels indicated that the concentration of
PrPSc in the scrapie source was at least two logs higher
compared to the BSE material. Conversely, it has been
shown the TSE infectivity cannot be accurately predicted
from quantitative laboratory test results [37]. A similar
approach has been followed in another study where it
was attempted to distinguish BSE from scrapie under
co-infection conditions using wild type mice [30]. In that
report the BSE and scrapie sources were mouse adaptedsources whilst in the current study we used ovine tissues
to replicate closer a scenario where potentially co-
infected ruminant tissues may be used to challenge
rodents.
Based on AR, IP and LP our data suggest that all three
mouse lines that were challenged with BSE/scrapie
mixtures exhibited a scrapie phenotype, and it was not
possible to identify any BSE attributes in the mixtures.
However, AR, IP and LP data are considered to be less
reliable parameters with lower discriminatory power
since they are based on average values derived from a
group of animals [16,38].
Each mouse that was challenged with either a BSE/
scrapie mixture or 100% scrapie control in the current
Figure 7 Assessment of intensity and distribution of BSE-associated punctate PrPSc deposits in the brain. The amount of BSE-associated
punctate PrPSc deposits was were assessed semiquantitatively from 0–4 in 27 neuroanatomical areas of clinically positive VM mice challenged
with BSE/scrapie mixtures and the scores were plotted against the areas. The brain areas scored were: 1, medulla; 2, locus coeruleus; 3 cerebellar
pedunculi; 4, cochlear nuclei; 5, dorsal cerebellum (granular layer); 6, inferior colliculus; 7, superior colliculus; 8, white matter in the mesencephalic
tegmentum; 9, medial geniculate nuclei; 10, peri-acquaductal grey matter; 11, Raphe nuclei; 12, red nuclei; 13, substantia nigra; 14, interpeduncular
nucleus; 15, hypothalamus; 16, lateral hypothalamus; 17, zona incerta; 18, anterior dorsal thalamic nuclei; 19, laterodorsal thalamic nuclei; 20, lateral
thalamus; 21, thalamus; 22, habenular bodies; 23, hippocampus; 24, septal nuclei of the paraterminal body; 25, nucleus of the vertical limb of the
diagonal band; 26, medial preoptic band; 27, ventral pallidum. The content of BSE in the BSE/scrapie mixtures was 50% (brown line), 10% (amber
line), 2% (red line) and 1% (blue line). Error bars indicate SEM.
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usually isolated from ARQ/ARQ scrapie cases [16,31,38]
although these sources comprise 40.32% of the scrapie
pool. In C57BL/6 or RIII mice this IHC pattern was in-
distinguishable from that observed in mice challenged
with 87A [34,38].
The Western blots from C57BL/6 and RIII mice that
were challenged with BSE/scrapie mixtures showed that
even with the highest BSE fraction (50%) the scrapie
characteristics dominated and any BSE signal was
undetectable within the resolution limits of this method.
Using IHC it was not feasible to identify any BSEFigure 8 The number of neuroantomical areas affected by
BSE-associated PrPSc deposits at four different coronal levels.
C1, C2, C3 and C4 correspond to medulla, midbrain, thalamic and
frontal coronal levels respectively. These four coronal levels (C1-C4) are
routinely used in TSE strain typing studies. The content of BSE in the
BSE/scrapie mixtures was 1% (blue columns), 2% (red columns), 10%
(amber columns) and 50% (brown columns). Error bars indicate SEM.characteristics in either C57BL/6 or RIII mice that were
challenged with BSE/scrapie mixtures so there is complete
agreement between IHC and Western blot data regarding
these two mouse lines. The difference in the PrPSc levels
between the scrapie and BSE sources could be a possible
explanation of this result.
Collectively the above data indicate that in the C57BL/6
and RIII mice that were challenged with BSE/scrapie mix-
tures only scrapie phenotypic traits were identified, sug-
gesting that either scrapie propagated preferentially at the
expense of BSE or, that although BSE also propagated, it
had a recessive phenotype that was not observed in the
mice. The similarity of results obtained from C57BL/6 and
RIII mice is likely explained by the fact that these two
mouse lines share the same PrP sequence (Prnp-a), that
influences the phenotypic features of TSE strains [38-40].
Propagation of a mixture of strains is supported by the
data from the VM mice where, while the overall IHC
characteristics of scrapie prevailed, a subtle but distinct
BSE feature was observed in mice challenged with BSE/
scrapie mixtures, and that feature was more prominent
in the mice that were exposed to high content of BSE
(10% or 50%) compared to those that received a low
content of BSE (1% or 2%). Although we were able to
identify a BSE associated trait that could potentially be
used to detect BSE in the presence of scrapie using VM
mice, the current study shows that overall scrapie can
dominate the phenotype of the disease even if BSE
prions propagate in the background, while some pheno-
typic aspects of BSE may be evident. This disparity in
the properties of different mouse lines could be attrib-
uted to the different PrP sequences between VM and
C57BL/6 or RIII mice. However, the VM data show evi-
dence that BSE and scrapie can co-exist in the same
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a dominant scrapie phenotype.
Great care must be taken, however, when attempting
to make any generalizations from this data. Firstly the
infectious titre of each of the two sources that were used
to produce the mixtures was not evaluated therefore the
mixtures did not reflect titre ratios but simply volumet-
ric fractions. Although, according to some researchers, it
would have been preferable to use titrated material this
would have prolonged the length of the study by at least
another two years. In addition, titres are the function of
the strain/ host combination used (BSE is usually titrated
in RIII mice whilst scrapie is usually titrated in C57BL/6
mice) and cross reading between different strain/host
systems is not always informative or appropriate. There-
fore it is questionable whether titre matching provides
an optimal approach to co-infection experiments. It
could also be argued that the mixtures could have been
based on PrPSc concentration. However, the content of
PrPSc in an inoculum may not always correlate directly
with infectivity [37]. Further evidence that this may be
the case is provided by reports that although PrPSc levels
in ovine BSE can be lower compared to cattle BSE in-
fectivity titres between the two samples can be similar
[41-43]. Nevertheless, in the current study both sources
generated presented fairly high AR and short IP com-
pared to similar inocula that have been previously bioas-
sayed in our institute in all three wild type mouse lines
used indicating that both had relatively high infectivity
[31,32]. The interactions between different scrapie strains
and BSE is another parameter that must be considered. In
this study all mice showed IHC patterns that were associ-
ated with scrapie strains that are related to the ARQ/ARQ
genotype, 87A in Prnp-a mice and 87 V in Prnp-b mice
[31,38,44]. It is not possible to predict how other scrapie
strains, such as ME7 or 221C, would interact with BSE.
Since the initiation of the current study transgenic
mouse lines which are more sensitive to specific animal
TSEs have been introduced and validated. Such lines are
relatively new, but promising, as intermediate phenotypes
have been identified after challenge with BSE/scrapie mix-
tures prepared in vitro [45,46]. However, these preliminary
data require further validation to evaluate the ability of
these models to detect BSE in the presence of scrapie. Re-
cently, a serial protein misfolding cyclic amplification
assay (sPMCA) has been developed to specifically detect
classic BSE even within the presence of scrapie prions. It
has been reported that in a blind trial, this sPMCA-based
assay specifically amplified BSE PrPSc within brain mixes
with 100% specificity and 97% sensitivity when BSE agent
was diluted into scrapie-infected brain homogenates at 1%
(vol/vol) [47]. Compared to mouse bioassay this in vitro
technique may offer a quick, reliable and more cost effect-
ive method in detecting BSE in the presence of scrapie.The fact that we were able to identify a marker to de-
tect BSE against a specific scrapie strain background in
VM mice does not mean that this is an acceptable test
for BSE detection in co-infected material. It does, how-
ever, give further understanding of the potential and
limitations of such an approach, which is relevant to the
retrospective interpretation of historical data in this
field, in particular to prevent the over-interpretation of
‘absence of BSE’ conclusions. It must be noted that the
selected marker is subtle and only an experienced obser-
ver could interpret it correctly and consistently in the
high content BSE inocula (10% or 50%), as in the low
content BSE mixtures (1% and 2%) the levels of the
marker dropped appreciably. Therefore, even using this
IHC model, low BSE levels on a scrapie background may
remain undetected. Theoretically similar caveats may
apply to the natural host ie small ruminants, where there
is a range of strain and host genotype combinations.
Consequently, the diagnostic methodology applied in
surveillance schemes may fail to identify co-infection
cases where BSE is present. In the view of the authors,
under these circumstances, the current policy of eradi-
cating or minimizing scrapie rather than attempting to
detect and manage BSE separately remains, scientifically
and financially, the most feasible option to prevent BSE
from entering the food chain via small ruminants.
Conclusions
In conclusion, our data suggest that by applying immu-
nohistochemistry to detect different PrPSc types in
the brains of mice challenged with BSE/scrapie mixtures
it is possible to detect BSE in a BSE/Scrapie co-infection
scenario. We also provide evidence that in principle
co-infection of BSE and scrapie cannot be excluded at
least in an experimental model.
Materials and methods
Ethical statement
All animal procedures were performed in compliance
with the Animal (Experimental Procedures) Act 1986
under license issued by the UK Home Office (license
number PPL70/5155), and were approved by the local
ethics committee.
Inoculum preparation
Initially a scrapie and an ovine BSE homogenate were
prepared. The scrapie inoculum, hereafter referred to as
100% scrapie, was made using a pool of brains collected
between 1996 and 1999 from confirmed cases of natural
scrapie representing the most frequent PrP genotypes
affected by scrapie (Table 2). The ovine BSE inoculum,
hereafter referred to as 100% BSE, was prepared from a
pool of ARQ/ARQ sheep brains which had been chal-
lenged experimentally with bovine BSE and subsequently
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nised using a handheld blender and made into a 10%
suspension in normal saline. These 10% suspensions
were filtered through a single layer of sterile gauze to re-
move large pieces of tissue, tested for microbiological
sterility and treated with antibiotics if necessary. Ali-
quots of these two inocula were combined to produce
mixtures of BSE and scrapie at the following relative ra-
tios: 1% BSE :99% scrapie (hereafter referred to as 1%
BSE), 2% BSE :98% scrapie (hereafter referred to as 2%
BSE), 10% BSE:90% scrapie (hereafter referred to as
10% BSE) and 50% BSE:50% scrapie (hereafter referred
to as 50% BSE). All homogenates were stored at −80°C
until they were used for inoculations.
Animal procedures
Each inoculum was administered into three panels of
wild type mice namely C57BL/6, RIII and VM. Each
panel consisted of 20 mice and each mouse received 20
μl of homogenate intracerebrally and 100 μl intraperito-
nially. Intracerebral inoculations were performed under
general anaesthesia using a 25 G hypodermic needle at-
tached to a 0.5 ml insulin syringe. A plastic sheath was
inserted along the needle allowing approximately 5 mm
of free end of the needle to be exposed to ensure that
the inoculum was deposited at similar depth in each ani-
mal and to minimize tissue injury. The point of entry was
approximately 3 mm dorsal to a point lying halfway be-
tween the eye and the base of the ear. Insertion into the
CNS was achieved by gently rotating the syringe along its
axis at a right angle with respect to the skull surface.
Mice were housed in standard mouse cages and were
monitored for clinical signs of disease by experienced
animal attendants. Mice were euthanized after exhibiting
clinical signs of TSE for two consecutive weeks or having
received scores of “definitely affected” in 2 out of 3 con-
secutive weeks unless the clinical progression of the disease
was so rapid that animals had to be euthanized on welfare
grounds. Mice that did not show clinical signs of TSE were
allowed to live until they were euthanized on welfare
grounds due to other conditions (intercurrent deaths).At postmortem the brain of each mouse was removed
sectioned along a parasagittal plane into two parts. One
third of the brain was stored at −80°C for further bioassay
or biochemical studies and two thirds were immersed in
buffered formalin for 72 hours at room temperature.
After fixation was completed each brain was cut at 4 dif-
ferent coronal points at the level of medulla (including the
cerebellum), midbrain, thalamus (including hippocampus
and overlying cortex) and frontal cortex (including basal
ganglia). Each coronal segment was embedded in paraffin
wax and histological sections (3 μm thick) from each level
were mounted on the same positively charged slide for
interpretation.
Histopathological assessment
Slides were stained with haematoxylin and eosin accord-
ing to standard methodology [48]. TSE diagnosis was
based on the presence of TSE specific vacuolation and
each sample was diagnosed as TSE positive, negative or
inconclusive. On TSE positive samples the lesion intensity
in specific neuroanatomical areas was further assessed
semi-quantitatively and assigned a score on a scale 0–5
(grey matter areas) or 0–3 (white matter areas). The lesion
scores from clinically and histopathologcally positive sam-
ples were plotted against the respective brain areas to pro-
duce lesion profiles as described previously [32,49].
Enzyme immunoassay
Inocula samples were analysed using a modified version
of the IDEXX Herdchek BSE – Scrapie EIA kit (IDEXX
laboratories, One IDEXX Drive, Westbrook, Maine 04092,
USA). Inocula samples were serially diluted in equal
volumes of TSE negative ovine brain homogenate (10%
(w/v)) prepared in IDEXX kit homogenisation buffer.
Diluted samples were treated as if they were normal
test homogenates (normally prepared as 25% (w/v))
and assayed following manufacturer’s instructions.
Briefly, diluted samples were mixed 4:5 with kit plate
diluent, distributed (100 μl) to the test plate and incu-
bated for 180 minutes at ambient room temperature
(RT). After washing, bound sample was incubated with
conditioning buffer for 10 minutes at RT, washed a sec-
ond time and incubated with horseradish peroxidase
conjugated anti-PrP antibody (SRB-CC) for 90 minutes
at RT. After final wash visualisation of bound PrPSc was
achieved using 3,3′,5,5′-tetramethylbenzidine (TMB) sub-
strate for 20 minutes at RT and measuring colour develop-
ment at 450 nm using a reference filter at 620 nm (Perkin
Elmer Envision 2104 multi-label reader).
Western blot
All samples, solid tissue and inocula, were analysed
using the Bio-Rad TeSeE™ Western blot (Bio-Rad
Laboratories Ltd., Hemel Hempstead, Hertfordshire, UK).
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according to manufacturer’s instructions. Briefly, 20% (w/v)
tissue homogenates were treated with proteinase K before
alcohol precipitation. After centrifugation, pellets were
solubilised in Laemmli buffer. Following extraction proteins
were separated on 12% Bis/Tris gels then electrotransferred
to PVDF membrane. After blocking the membrane with
5% bovine serum albumin (BSA) proteins were labelled
with anti-prion antibodies Sha31 (epitope: ovine amino acid
sequence 145–152) and 12B2 (epitope: ovine amino acid
sequence 97–115). Visualisation was achieved using
enhanced chemiluminesence (ECL) reagents (Amersham
Biosciences; Little Chalfont, Buckinghamshire UK).
Prior to biochemical analysis of inoculum samples by
Bio-Rad TeSeE™ Western blot, aliquots of finalised
inocula were centrifuged at 350000 g for 30 minutes.
The resulting pellet was re-homogenised at 20% (w/v) in
Bio-Rad kit homogenisation buffer and the resultant
homogenate treated as described above.
Prior to biochemical analysis of inoculum samples by
Bio-Rad TeSeE™ Western blot, aliquots of finalised
inocula were centrifuged at 350000 g for 30 minutes.
The resulting pellet was re-homogenised at 20% (w/v) in
Bio-Rad kit homogenisation buffer and the resultant
homogenate treated as described above.
Immunohistochemical labelling of PrPSc
Samples from clinically and histopathologically positive
mice were further analysed with IHC as described previ-
ously [16,31]. PrPSc was detected using the rabbit poly-
clonal anti-PrP antibody Rb486 according to standard
methodology [48].
Statistical analysis
Cluster analysis was performed using Statistica (Version 10).
For all other statistical analyses the STATA (Version 10) or
the Graph Pad Prism (Version 6.04) programmes were used.
Additional file
Additional file 1: Figure S1. Cluster analysis of vacuolation score data.
Vacuolation was assessed semiquantitatively in the same areas used for
lesion profiling. The analysis shows that in all three mouse lines the BSE/
scrapie mixtures group together with the scrapie control and this cluster
is clearly separated from the BSE control.
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